MUC5B, a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis (IPF)

Grant

Awarded By

Total Award Amount

  • 159516.00

    • Direct Costs

  • 108514.00

    • Sponsor Award Id

  • FY15.576.016

    • Contributor

  • Aaron Carter   Principal Investigator